List of GLP-1 Agonists for Metabolic Health Support
Explore FDA-approved GLP-1 agonists and how licensed providers may use them to support metabolic health goals.
Discover how semaglutide supports metabolic health by working with your body’s natural systems. Learn how licensed providers may help guide your journey.
Understanding how semaglutide works in the body may help individuals feel more confident about discussing treatment options with a licensed healthcare provider. Semaglutide belongs to a class of medications known as GLP-1 receptor agonists, which may support the body’s natural hormone systems that regulate blood sugar and appetite signals.
Eden is a digital health platform that connects individuals with licensed healthcare providers for evaluation and potential access to GLP-1 treatment programs. Eden does not practice medicine, manufacture, or dispense medications.
Semaglutide is a medication that mimics the action of glucagon-like peptide-1 (GLP-1), a hormone that plays a role in how the body processes food. It works by stimulating insulin release when blood sugar is high, reducing glucagon (a hormone that raises blood sugar), and communicating satiety signals to the brain.
Semaglutide has been approved by the U.S. Food and Drug Administration (FDA) for managing type 2 diabetes and, in certain formulations, for chronic weight management in adults with specific medical conditions. Research continues to explore its effects on other aspects of metabolic health. Licensed providers may evaluate these findings when determining appropriate treatment options.
Once semaglutide is in the body, it binds to GLP-1 receptors in the brain and digestive system. This interaction may support the following processes:
Together, these effects may support a more balanced metabolic state. However, individual results vary, and a licensed healthcare provider will determine whether semaglutide is a good fit based on a comprehensive health evaluation.
{{primary-cta}}
If a licensed healthcare provider determines that semaglutide is appropriate, the medication may be introduced gradually to minimize side effects such as nausea, changes in appetite, or digestive discomfort.
A successful treatment plan often includes:
Licensed providers on the Eden platform monitor progress, adjust dosing as needed, and offer ongoing support to help optimize outcomes.
Eden is a digital health platform that makes it easier to connect with licensed healthcare providers who can evaluate your health and discuss whether a GLP-1 treatment plan is right for you.
If semaglutide is prescribed, it is filled by an independent, state-licensed pharmacy and shipped directly to your door. All medical decisions are made solely by the licensed healthcare provider you consult with through the platform.
Eden does not practice medicine, manufacture medications, or own any pharmacies.
{{primary-cta}}
Semaglutide may support aspects of metabolic health by working with the body’s natural systems that help regulate appetite and blood sugar. While individual responses vary, licensed providers may consider it as part of a broader wellness-focused care plan.
For those interested in exploring whether semaglutide could support their health goals, Eden offers access to licensed providers who will evaluate your needs and guide your journey.
This content is for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider. Eden is not a medical provider or a pharmacy. Eden connects individuals with independent licensed healthcare providers who independently evaluate each patient to determine whether a prescription treatment program is appropriate. All prescriptions are written at the sole discretion of the licensed provider. Medications are filled by independent, state-licensed pharmacies. Eden does not manufacture, own, or dispense any medications. No health claims are made unless supported by multiple peer-reviewed studies. Please consult a licensed healthcare provider before making any medical decisions.
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
Collins, L., & Costello, R. A. (2024, February 29). Glucagon-Like peptide-1 receptor agonists. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK551568/